ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,838 | +29.9% | 14,731 | +26.0% | 0.00% | 0.0% |
| Q2 2023 | $232,340 | +13.5% | 11,693 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $204,686 | -1.9% | 11,949 | +12.1% | 0.00% | 0.0% |
| Q4 2022 | $208,597 | +126.7% | 10,659 | +85.0% | 0.00% | 0.0% |
| Q3 2022 | $92,000 | +16.5% | 5,762 | 0.0% | 0.00% | – |
| Q2 2022 | $79,000 | -13.2% | 5,762 | 0.0% | 0.00% | – |
| Q1 2022 | $91,000 | -37.2% | 5,762 | -13.3% | 0.00% | -100.0% |
| Q4 2021 | $145,000 | +3.6% | 6,645 | +41.4% | 0.00% | 0.0% |
| Q3 2021 | $140,000 | -33.0% | 4,699 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $209,000 | +1.0% | 4,708 | +0.8% | 0.00% | 0.0% |
| Q1 2021 | $207,000 | -35.5% | 4,671 | -20.2% | 0.00% | -50.0% |
| Q4 2020 | $321,000 | +339.7% | 5,856 | +82.4% | 0.00% | +100.0% |
| Q3 2020 | $73,000 | +9.0% | 3,211 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $67,000 | +191.3% | 3,211 | +95.3% | 0.00% | – |
| Q1 2020 | $23,000 | -37.8% | 1,644 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | +94.7% | 1,644 | 0.0% | 0.00% | – |
| Q3 2019 | $19,000 | -24.0% | 1,644 | 0.0% | 0.00% | – |
| Q2 2019 | $25,000 | +66.7% | 1,644 | +98.1% | 0.00% | – |
| Q1 2019 | $15,000 | +25.0% | 830 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -40.0% | 830 | 0.0% | 0.00% | – |
| Q3 2018 | $20,000 | – | 830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |